Open Access
| Numéro |
Med Sci (Paris)
Volume 35, Numéro 8-9, Août–Septembre 2019
|
|
|---|---|---|
| Page(s) | 616 - 618 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2019120 | |
| Publié en ligne | 18 septembre 2019 | |
- Organisation Mondiale de la Santé. Global hepatitis report. Genève: OMS, 2017 [Google Scholar]
- Hamdane N, Baumert T, Zeisel MB. Carcinome hépatocellulaire après éradication du virus de l‘hépatite C par des antiviraux à action directe. Med Sci (Paris) 2018 ; 34 : 391–394. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
- Bartenschlager R, Baumert TF, Bukh J, et al. Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: considerations for scientists and funding agencies. Virus Res 2018 ; 248 : 53–62. [CrossRef] [PubMed] [Google Scholar]
- Bartosch B, Verney G, Dreux M, et al. An interplay between the hyper-variable region 1 of the HCV E2 glycoprotein, the scavenger receptor BI and HDL promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 2005 ; 79 : 8217–8229. [CrossRef] [PubMed] [Google Scholar]
- André P, Komurian-Pradel F, Deforges S, et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002 ; 76 : 6919–6928. [CrossRef] [PubMed] [Google Scholar]
- Dreux M, Pietschmann T, Granier C, et al. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. J Biol Chem 2006 ; 281 : 18285–18295. [CrossRef] [PubMed] [Google Scholar]
- Merz A, Long G, Hiet MS, et al. Biochemical and morphological properties of HCV particles and determination of their lipidome. J Biol Chem 2011 ; 286 : 3018–3032. [CrossRef] [PubMed] [Google Scholar]
- Dao Thi VL, Granier C, Zeisel MB, Guérin M, et al. Characterization of hepatitis C virus particle subpopulations reveals multiple usage of SRBI for entry steps. J Biol Chem 2012 ; 287 : 31242–31257. [CrossRef] [PubMed] [Google Scholar]
- Podevin P, Carpentier A, Pene V, et al. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes. Gastroenterology 2010 ; 139 : 1355–1364. [CrossRef] [PubMed] [Google Scholar]
- Calattini S, Fusil F, Mancip J, et al. Functional and biochemical characterization of Hepatitis C virus (HCV) particles produced in a humanized liver mouse model. J Biol Chem 2015 ; 290 : 23173–23187. [CrossRef] [PubMed] [Google Scholar]
- Denolly, Granier C, Fontaine N, et al. A serum protein factor mediates maturation and apoB-association of HCV particles. J Hepatol 2019; 70 : 626–38. [CrossRef] [PubMed] [Google Scholar]
- Lavillette D, Morice Y, Germanidis G, et al. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection. J Virol 2005 ; 79 : 6023–6034. [CrossRef] [PubMed] [Google Scholar]
- Fafi-Kremer S, Fauvelle C, Felmlee DJ, et al. Neutralizing antibodies and pathogenesis of hepatitis C virus infection. Viruses 2012 ; 4 : 2016–2030. [CrossRef] [PubMed] [Google Scholar]
- Prentoe J, Serre SB, Ramirez S, et al. HVR1 deletion and required adaptive envelope mutations confer decreased dependancy on SRBI and LDLr for HCV. J Virol 2014 ; 88 : 1725–1739. [CrossRef] [PubMed] [Google Scholar]
Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.
Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.
Le chargement des statistiques peut être long.